| Literature DB >> 35515026 |
Avtar Singh1, Soottawat Benjakul1, Nurul Huda2, Changan Xu3, Peng Wu3.
Abstract
Chitooligosaccharide (COS) and epigallocatechin-3-gallate (EGCG) at various concentrations were used for the preparation of COS-EGCG conjugates. The highest total phenolic content (TPC), representing the amount of EGCG conjugated, was obtained for 1 wt% COS together with EGCG at 0.5 wt% (C1-E0.5-conjugate) or 1.0 wt% (C1-E1.0-conjugate) (66.83 and 69.22 mg EGCG per g sample, respectively) (p < 0.05). The 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activities (DRSA and ARSA, respectively) and ferric reducing antioxidant power (FRAP) of all the samples showed similar trends with TPC. The C1-E0.5-conjugate had higher DRSA, ARSA, FRAP and oxygen radical absorbance capacity (ORAC) values than COS (p < 0.05). Similarly, the antimicrobial activity of COS increased when conjugated with EGCG (p < 0.05). FTIR, 1H-NMR and 13C-NMR analyses confirmed the successful grafting of EGCG with COS. Therefore, 1 wt% COS and 0.5 wt% EGCG were used for the production of a conjugate with augmented antioxidant activity, which could be used to retard lipid oxidation of fatty foods. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35515026 PMCID: PMC9056682 DOI: 10.1039/d0ra05548d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Proposed mechanism for synthesis of chitooligosaccharide (COS) and epigallocatechin gallate (EGCG) conjugate via ascorbic acid/H2O2 redox pair mediated free radical grafting method.
Total phenolic content (TPC) and antioxidative activities of conjugates prepared using chitooligosaccharide (COS) and EGCG at different concentrationsa
| COS–EGCG conjugates | TPC (mg EGCG equivalent per g sample) | DRSA (mmol TE per g sample) | ARSA (mmol TE per g sample) | FRAP (mmol TE per g sample) |
|---|---|---|---|---|
| C1-E0.1 | 15.59 ± 0.73bF | 41.63 ± 2.89bB | 38.10 ± 1.85bD | 54.18 ± 3.6cF |
| C1-E0.5 | 66.83 ± 5.52aB | 49.21 ± 3.53aA | 145.54 ± 4.99aA | 419.78 ± 4.69aB |
| C1-E1.0 | 69.22 ± 4.28aA | 51.69 ± 3.19aA | 147.42 ± 5.00aA | 422.69 ± 3.14aA |
| C2-E0.1 | 20.16 ± 1.57cE | 31.08 ± 1.09cD | 24.06 ± 1.29cE | 65.81 ± 7.92cE |
| C2-E0.5 | 46.10 ± 2.18bD | 36.02 ± 3.03bC | 77.16 ± 4.69bC | 190.15 ± 8.94bD |
| C2-E1.0 | 63.88 ± 2.95aC | 40.28 ± 2.88aB | 121.72 ± 14.24aB | 380.80 ± 22.29aC |
Values are presented as mean ± SD (n = 3). Different lowercase letters within the same COS concentration in the same column indicate a significant difference (p < 0.05). Different uppercase letters in the same column indicate a significant difference (p < 0.05). C1-E0.1: conjugates prepared using 1 wt% COS and 0.1 wt% EGCG, C1-E0.5: conjugates prepared using 1 wt% COS and 0.5 wt% EGCG and C1-E1.0: conjugates prepared using 1 wt% COS and 1 wt% EGCG. C2-E0.1: conjugates prepared using 2 wt% COS and 0.1 wt% EGCG, C2-E0.5: conjugates prepared using 2 wt% COS and 0.5 wt% EGCG, C2-E1.0: conjugates prepared using 2 wt% COS and 1 wt% EGCG.
Fig. 413C NMR spectra of chitooligosaccharide (COS) (A) and the selected conjugate (C1-E0.5) (B). C1-E0.5-conjugate was prepared using 1 wt% COS and 0.5 wt% EGCG.
Antioxidant and antimicrobial activities of the selected COS–EGCG conjugate in comparison with COSa
| Activities | Samples | |||
|---|---|---|---|---|
| COS | C1-E0.5-conjugate | |||
| Antioxidant activities | DRSA (mmol TE per g sample) | 0.50 ± 0.21b | 41.69 ± 5.60a | |
| ARSA (mmol TE per g sample) | 4.22 ± 2.64b | 123.03 ± 15.47a | ||
| FRAP (mmol TE per g sample) | 6.96 ± 1.96b | 390.29 ± 17.98a | ||
| ORAC (mmol TE per g sample) | 0.18 ± 0.01b | 12.17 ± 1.40a | ||
| MCA (mmol EE per g sample) | 1.54 ± 0.16b | 77.27 ± 1.43a | ||
| Antimicrobial activities |
| MIC (mg mL−1) | 0.05 ± 0.00a | 0.01 ± 0.00b |
| MBC (mg mL−1) | 0.1 ± 0.00a | 0.05 ± 0.01b | ||
|
| MIC (mg mL−1) | 2.00 ± 0.09a | 1.00 ± 0.12b | |
| MBC (mg mL−1) | 2.00 ± 0.10a | 1.00 ± 0.10b | ||
Values are presented as mean ± SD (n = 3). Different lowercase letters within the same row indicate a significant difference (p < 0.05). COS: chitooligosaccharide, C1-E0.5-conjugate: conjugate prepared using 1 wt% COS and 0.5 wt% EGCG.
Fig. 2FTIR spectra of epigallocatechin gallate (EGCG) () chitooligosaccharide (COS) () and the selected conjugate (C1-E0.5) conjugate (⋯). C1-E0.5-conjugate was prepared using 1 wt% COS and 0.5 wt% EGCG.
Fig. 31H NMR spectra of chitooligosaccharide (COS) (A) and the selected conjugate (C1-E0.5) (B). C1-E0.5-conjugate was prepared using 1 wt% COS and 0.5 wt% EGCG.
1H NMR and 13C NMR signals of the selected COS–EGCG conjugate in comparison with COSa
| 1H NMR | 13C NMR | ||||
|---|---|---|---|---|---|
| Source of H-signal |
| Source of C-signal |
| ||
| COS | C1-E0.5-conjugate | COS | C1-E0.5-conjugate | ||
| H1 | 5.08 | * | C2 | 58.98 | 59.02 |
| C6 | 62.87 | 63.75 | |||
| H2 | 3.12 | * | C5 | 74.7 | * |
| H3–H6 | 3.3–4.0 | * | C3 | 80.05 | * |
| C4 | 75.28 | * | |||
| NH- and OH-groups | 1.97 | * | C1 | 102.6 | * |
| A and C rings | ND | 58–80 | |||
| Aromatic protons | ND | 7.0 | B and D rings | ND | 100–170 |
COS: chitooligosaccharide, C1-E0.5-conjugate: conjugate prepared using 1 wt% COS and 0.5 wt% EGCG. ND: not detected. *Samples showed similar signals (no chemical shifts after conjugation). A, B, C and D rings are belonging to EGCG structure (Fig. 4B).